CHENE, Laurent,BONNY, Christophe,STROZZI, Francesco
申请号：
AU2019253217
公开号：
AU2019253217A1
申请日:
2019.04.11
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
The present invention relates to antigen-based immunotherapy, in particular cancer immunotherapy. In particular, the present invention provides antigenic peptides, which are distinct from, but have amino acid similarity to, fragments of human tumor antigens. The present invention further provides immunogenic compounds, nanoparticles, cells and pharmaceutical compositions comprising such antigenic peptides and nucleic acids encoding such antigenic peptides.
